{
  "schemaVersion": 2,
  "eyebrow": "Endocrinology",
  "title": "Thyrotoxicosis Diagnostic Testing",
  "summary": "Confirm biochemical thyrotoxicosis with TSH and free thyroid hormones, then distinguish hormone overproduction from destructive or exogenous release using TRAb and uptake-pattern testing to direct definitive management.",
  "seoDescription": "A physician-focused approach to confirming thyrotoxicosis and distinguishing Graves disease, autonomous nodules, thyroiditis, and exogenous hormone use.",
  "clinicalQuestion": "How should clinicians confirm thyrotoxicosis and identify the etiologic pattern that changes immediate and definitive management?",
  "specialty": "Endocrinology",
  "audience": "U.S. physicians and medical trainees",
  "tags": [
    "thyrotoxicosis workup",
    "suppressed TSH",
    "TRAb",
    "TSI",
    "radioactive iodine uptake",
    "Graves disease diagnosis",
    "toxic adenoma",
    "thyroiditis",
    "factitious thyrotoxicosis"
  ],
  "keyTakeaways": [
    "Use serum TSH as the initial screen; a suppressed TSH with elevated free T4 and/or T3 establishes overt biochemical thyrotoxicosis. Obtain T3 when free T4 does not confirm suspected hyperthyroidism because T3 toxicosis can occur. [5][7][8]",
    "In suspected Graves disease, a positive TRAb or TSI confirms the diagnosis without further etiologic testing; if antibodies are negative or unavailable and Graves features are absent, obtain thyroid uptake imaging when appropriate. [9][4]",
    "Radioiodine uptake separates increased synthesis from destructive or exogenous thyrotoxicosis: diffuse uptake supports Graves disease, focal uptake supports toxic adenoma, patchy uptake supports toxic multinodular goiter, and low uptake suggests thyroiditis or exogenous hormone exposure. [4][5]",
    "Low uptake plus low thyroglobulin supports factitious thyrotoxicosis; reduced thyroid vascularity on Doppler ultrasonography provides an additional discriminator. [4]",
    "Identify possible thyroid storm immediately in a patient with severe systemic decompensation, altered mental status, or cardiovascular collapse; the condition has high mortality and requires urgent treatment while diagnostic testing proceeds. [4]"
  ],
  "sections": [
    {
      "id": "triage-and-biochemical-confirmation",
      "eyebrow": "First decision",
      "heading": "Identify instability and confirm the biochemical pattern",
      "intro": "Test urgently when clinical severity could indicate thyroid storm or major cardiovascular complications.",
      "paragraphs": [
        "Prioritize immediate assessment for delirium or altered mental status, seizure, atrial fibrillation, heart failure, thromboembolic disease, cardiovascular collapse, or severe systemic illness. These complications can accompany thyrotoxicosis; thyroid storm carries high mortality and warrants a high index of suspicion in a compatible presentation or risk setting. Obtain TSH, free T4, and free T3 while urgent stabilization and cause-directed assessment proceed. [4]",
        "Start biochemical testing with serum TSH. Thyrotoxicosis usually produces concordant elevation of T4 and T3 with suppressed TSH, and TSH is the recommended frontline screening test. Newly presenting Graves disease usually fully suppresses TSH to less than 0.05 mU/L; a low TSH of 0.1 to 0.4 mU/L should prompt consideration of alternative explanations for symptoms rather than presuming new Graves disease. [5][7]",
        "If TSH is suppressed, measure both free T4 and T3. T3 should be obtained when free T4 does not clearly verify suspected hyperthyroidism because T3 toxicosis may present with normal total T4 and free T4 but diagnostic T3 elevation. In acutely ill patients with low TSH but normal free T4 and normal T3, follow thyroid testing during recovery because some subsequently develop overt thyrotoxicosis. [8]"
      ],
      "bullets": [
        "Interpret total T4 and total T3 cautiously when binding proteins are altered: pregnancy and exogenous estrogen increase thyroxine-binding globulin and thereby increase total, but not free, hormone concentrations. [7]",
        "Take a medication and supplement history before assigning an endogenous thyroid diagnosis because commonly used drugs can cause thyroid dysfunction and can interfere with thyroid testing. [7]",
        "Do not use TSH alone when clinical circumstances make it misleading; interpret TSH with free hormone concentrations and the patient's clinical setting. [7]"
      ],
      "subsections": [],
      "table": {
        "caption": "Initial biochemical interpretation in suspected thyrotoxicosis. [5][7][8]",
        "columns": [
          "Test pattern",
          "Interpretation",
          "Next diagnostic action"
        ],
        "rows": [
          [
            "Suppressed TSH plus elevated free T4 and/or T3",
            "Overt biochemical thyrotoxicosis. [5][7]",
            "Proceed to etiologic testing with TRAb/TSI or uptake-pattern testing. [4][9]"
          ],
          [
            "Suppressed TSH, normal free T4, elevated T3",
            "T3 toxicosis is possible. [8]",
            "Determine cause using Graves antibody testing or thyroid uptake imaging. [4][9]"
          ],
          [
            "TSH 0.1-0.4 mU/L in a patient suspected of new Graves disease",
            "Another explanation for symptoms is likely; do not infer Graves disease from this range alone. [5]",
            "Review clinical context, medications, and free hormone results before etiologic imaging. [5][7]"
          ],
          [
            "Low TSH with normal free T4 and normal T3 during nonthyroidal illness",
            "May reflect acute illness; some patients develop thyrotoxicosis on recovery. [8]",
            "Repeat thyroid function testing after recovery if suspicion persists. [8]"
          ]
        ]
      }
    },
    {
      "id": "choose-etiologic-test",
      "eyebrow": "Etiology",
      "heading": "Use TRAb first when Graves disease is plausible",
      "intro": "The central branch point is autonomous hormone synthesis versus destructive or exogenous hormone release.",
      "paragraphs": [
        "After overt thyrotoxicosis is confirmed, seek clinical evidence of Graves disease: diffuse goiter, thyroid eye disease, and, less commonly, thyroid dermopathy increase its likelihood. Measure thyrotropin receptor antibodies (TRAb) or thyroid-stimulating immunoglobulins (TSI) when Graves disease is suspected. A positive TRAb or TSI result confirms Graves disease without further diagnostic testing. [5][9]",
        "Prefer TRAb or TSI over thyroid peroxidase antibody testing for etiologic confirmation of Graves disease. TPO antibody testing alone is less useful for this decision, although absent TRAb with positive TPO antibodies can support a process more likely to resolve spontaneously in selected cases. [6]",
        "If TRAb or TSI is negative, remember that Graves disease is not completely excluded. Proceed to thyroid uptake testing when the diagnosis remains uncertain and the result will distinguish Graves disease from autonomous nodular disease, thyroiditis, or exogenous hormone use. Scintigraphy has approximately 96% diagnostic accuracy, but Graves disease can show nonuniform or normal uptake in 5% to 12% of cases. [1][9]"
      ],
      "bullets": [
        "Use TRAb/TSI as the initial etiologic test when diffuse goiter or eye disease suggests Graves disease. [5][9]",
        "Do not rely on TPO antibody positivity alone to diagnose Graves disease. [6]",
        "Move to uptake imaging after negative or unavailable Graves antibody testing when etiology remains clinically consequential. [4][9]"
      ],
      "subsections": [],
      "table": {
        "caption": "Testing sequence when Graves disease is considered. [4][5][6][9]",
        "columns": [
          "Clinical situation",
          "Preferred test",
          "Result that changes the next step"
        ],
        "rows": [
          [
            "Diffuse goiter or thyroid eye disease with overt thyrotoxicosis",
            "TRAb or TSI. [5][9]",
            "Positive result confirms Graves disease; no further etiologic test is needed. [9]"
          ],
          [
            "Suspected Graves disease with negative TRAb/TSI",
            "Radioactive iodine uptake test or thyroid scan. [9]",
            "Diffuse uptake can support Graves disease; focal or patchy uptake redirects evaluation toward autonomous nodular disease. [4][5]"
          ],
          [
            "TRAb/TSI unavailable",
            "Radioactive iodine uptake test or thyroid scan. [9]",
            "Uptake pattern distinguishes diffuse, focal, patchy, and low-uptake causes. [4][5]"
          ],
          [
            "Need an alternative when antibody and uptake testing are not readily available",
            "Thyroidal blood-flow assessment by ultrasonography may help establish Graves disease. [9]",
            "Use vascularity with biochemical and clinical findings rather than as a standalone diagnosis. [4][9]"
          ]
        ]
      }
    },
    {
      "id": "interpret-uptake-pattern",
      "eyebrow": "Imaging interpretation",
      "heading": "Interpret radioactive iodine uptake by pattern, not simply as normal or abnormal",
      "intro": "The scan result identifies whether thyroid tissue is actively synthesizing hormone and localizes autonomous activity.",
      "paragraphs": [
        "Obtain a radioactive iodine uptake study or thyroid scan in thyrotoxic patients who lack clinical Graves features or whose antibody result does not establish the cause. In Graves disease, uptake is usually diffusely increased; nodules or fibrosis can alter this appearance. A diffuse goiter with thyroid eye disease and positive TRAb remains the most coherent Graves pattern even when scan appearance is atypical. [4][5][1]",
        "A single toxic adenoma produces focal uptake within the autonomous nodule with suppression of uptake in surrounding thyroid tissue. Toxic multinodular goiter produces multiple focal areas of increased uptake with suppression of surrounding tissue; this pattern is often associated with older age, a nodular goiter, and an insidious presentation without eye signs. These high-uptake patterns indicate endogenous hormone overproduction and distinguish nodular autonomy from low-uptake thyrotoxicosis. [4][5]",
        "Low uptake redirects the workup away from hormone synthesis and toward destructive thyroiditis or exogenous thyroid hormone. In suspected factitious thyrotoxicosis, measure thyroglobulin: elevated T3/T4 with low TSH, low uptake, and low thyroglobulin supports exogenous thyroid supplement ingestion. Doppler ultrasonography may show reduced thyroid vascularization in this setting. [4]"
      ],
      "bullets": [
        "Diffuse high uptake: Graves disease is favored, especially with positive TRAb and eye disease. [5]",
        "Focal hot nodule with suppression of the remaining gland: toxic adenoma. [4][5]",
        "Multiple focal high-uptake areas with suppression between nodules: toxic multinodular goiter. [4][5]",
        "Low uptake: investigate destructive thyroiditis and exogenous thyroid hormone exposure; add thyroglobulin when factitious disease is possible. [4]"
      ],
      "subsections": [
        {
          "heading": "When Doppler ultrasonography adds value",
          "paragraphs": [
            "Use Doppler assessment of thyroidal blood flow when TRAb/TSI and uptake testing are not readily available, or as an adjunct when exogenous hormone ingestion is suspected. Reduced vascularization supports factitious thyrotoxicosis; blood-flow assessment may also help establish Graves disease in the appropriate clinical setting. [4][9]"
          ],
          "bullets": []
        }
      ],
      "table": {
        "caption": "Etiologic patterns after thyrotoxicosis is biochemically confirmed. [4][5]",
        "columns": [
          "Etiology",
          "Clinical discriminator",
          "Uptake or scan pattern",
          "Confirmatory or adjunctive test"
        ],
        "rows": [
          [
            "Graves disease",
            "Diffuse goiter, thyroid eye disease, rarely dermopathy. [5]",
            "High diffuse uptake, although nodules or fibrosis may modify the pattern. [4][5]",
            "TRAb positive. [5]"
          ],
          [
            "Toxic adenoma",
            "Palpable solitary thyroid nodule; eye signs are absent. [5]",
            "Focal uptake in the adenoma with suppression of surrounding thyroid tissue. [4][5]",
            "Correlate focal scan activity with thyroid examination. [5]"
          ],
          [
            "Toxic multinodular goiter",
            "Older patient, nodular goiter, insidious onset, no eye signs. [5]",
            "Multiple focal areas of increased uptake with suppression of surrounding tissue. [4][5]",
            "TRAb is usually negative. [5]"
          ],
          [
            "Factitious thyrotoxicosis",
            "History may reveal thyroid hormone or supplement ingestion. [4]",
            "Decreased uptake. [4]",
            "Low thyroglobulin; Doppler may show reduced vascularization. [4]"
          ],
          [
            "Destructive thyroiditis",
            "Consider when synthesis-pattern causes are not supported. [5]",
            "Low uptake distinguishes it from Graves disease and autonomous nodular disease. [4][5]",
            "Use clinical history, antibody testing, and low-uptake pattern to refine the cause. [5][6]"
          ]
        ]
      }
    },
    {
      "id": "resolve-discordant-results",
      "eyebrow": "Pitfalls",
      "heading": "Resolve discordant thyroid tests before assigning a definitive etiology",
      "intro": "Discordance should trigger review of assay context, hormone binding, illness, and exogenous exposure.",
      "paragraphs": [
        "When total hormone results and the clinical picture diverge, repeat evaluation with free hormone measurements and review conditions that alter binding proteins. Pregnancy and exogenous estrogen raise thyroxine-binding globulin, increasing total T4 without necessarily increasing free T4; total hormone results should therefore not be interpreted as equivalent to free hormone excess in these settings. [7]",
        "When a patient has a low TSH but free T4 and T3 are not elevated, do not equate the laboratory pattern with overt thyrotoxicosis. Acute nonthyroidal illness can produce this pattern, and repeat testing after recovery is appropriate when clinical suspicion remains. Conversely, obtain T3 in a patient with suppressed TSH and normal free T4 if symptoms or examination still suggest hyperthyroidism. [8]",
        "If a scan shows low uptake but the patient appears clinically hyperthyroid, specifically ask about prescribed levothyroxine, liothyronine, compounded thyroid preparations, weight-loss products, and supplements. A low thyroglobulin concentration materially strengthens the diagnosis of factitious thyrotoxicosis, whereas low uptake alone does not identify the source of hormone release. [4]"
      ],
      "bullets": [
        "Review all prescription drugs, over-the-counter products, and supplements before labeling antibody-negative thyrotoxicosis as thyroiditis. [7][4]",
        "Interpret a negative TRAb or TSI result with the scan pattern and examination because Graves disease can occasionally have negative antibodies or atypical uptake. [9][1]",
        "Use free rather than total thyroid hormone levels when altered binding protein states are likely. [7]"
      ],
      "subsections": [],
      "table": {
        "caption": "High-yield discordances and corrective actions. [1][4][7][8][9]",
        "columns": [
          "Discordance",
          "Likely explanation or concern",
          "Corrective action"
        ],
        "rows": [
          [
            "Symptoms suggest hyperthyroidism, free T4 normal, TSH suppressed",
            "T3 toxicosis can occur. [8]",
            "Measure T3. [8]"
          ],
          [
            "High total T4 in pregnancy or during exogenous estrogen use",
            "Increased thyroxine-binding globulin can raise total, not free, hormone concentrations. [7]",
            "Base interpretation on free hormone testing and clinical context. [7]"
          ],
          [
            "Negative TRAb/TSI but persistent Graves-like presentation",
            "Graves disease may be antibody-negative; nonuniform or normal uptake occurs in 5% to 12% of cases. [9][1]",
            "Obtain uptake imaging and integrate scan, examination, and antibody results. [1][9]"
          ],
          [
            "Low uptake with biochemical thyrotoxicosis",
            "Destructive thyroiditis or exogenous hormone exposure. [4][5]",
            "Measure thyroglobulin and obtain a focused hormone/supplement history. [4]"
          ]
        ]
      }
    },
    {
      "id": "pregnancy-and-postpartum",
      "eyebrow": "Special population",
      "heading": "Use pregnancy- and postpartum-specific thyroid guidance",
      "intro": "Pregnancy changes thyroid testing context and makes untreated thyrotoxicosis clinically consequential.",
      "paragraphs": [
        "In pregnancy or the postpartum period, use thyroid testing and etiologic assessment within pregnancy-specific guidance rather than applying nonpregnant total-hormone interpretation unmodified. Pregnancy increases thyroxine-binding globulin and can elevate total T4; free hormone measurements and the clinical context are therefore central to interpretation. [2][7]",
        "Do not defer evaluation of clinically significant thyrotoxicosis in pregnancy. Untreated disease has been associated with pregnancy loss, pregnancy-induced hypertension, prematurity, low birth weight, intrauterine growth restriction, stillbirth, thyroid storm, and maternal congestive heart failure. Coordinate etiologic diagnosis and management with clinicians experienced in thyroid disease during pregnancy. [2][3]"
      ],
      "bullets": [
        "Account for pregnancy-related binding-protein changes before interpreting total T4 or total T3. [7]",
        "Use the ATA pregnancy and postpartum guidance for diagnosis and management decisions in pregnant or postpartum patients. [2]",
        "Escalate promptly when maternal thyrotoxicosis is clinically significant because both maternal and fetal complications are reported with untreated disease. [3]"
      ],
      "subsections": [],
      "table": {
        "caption": "Pregnancy-related testing considerations. [2][3][7]",
        "columns": [
          "Situation",
          "Testing implication",
          "Clinical consequence"
        ],
        "rows": [
          [
            "Pregnancy or exogenous estrogen exposure",
            "Total T4 may rise because thyroxine-binding globulin increases; total hormone levels can be confounded. [7]",
            "Interpret free hormones and clinical context rather than total T4 alone. [7]"
          ],
          [
            "Overt thyrotoxicosis during pregnancy",
            "Prompt diagnostic evaluation is warranted under pregnancy-specific thyroid guidance. [2]",
            "Untreated thyrotoxicosis is associated with adverse maternal and fetal outcomes. [3]"
          ],
          [
            "Postpartum thyrotoxicosis",
            "Apply ATA pregnancy and postpartum guidance to etiologic assessment and treatment planning. [2]",
            "Differentiate Graves disease from thyroiditis because their expected course and management differ. [5][6]"
          ]
        ]
      }
    }
  ],
  "faq": [
    {
      "question": "When is a radioactive iodine uptake study most useful in thyrotoxicosis?",
      "answer": "Use uptake testing when Graves disease is not established clinically or by positive TRAb/TSI, particularly to distinguish diffuse Graves uptake, focal toxic adenoma uptake, patchy toxic multinodular uptake, and low-uptake thyroiditis or exogenous hormone exposure. [4][5][9]"
    },
    {
      "question": "What test best supports factitious thyrotoxicosis?",
      "answer": "The most supportive combination is suppressed TSH with elevated thyroid hormones, low radioactive iodine uptake, and low thyroglobulin; reduced thyroid vascularity on Doppler ultrasonography is an adjunctive finding. [4]"
    }
  ],
  "references": [
    {
      "number": 1,
      "title": "Diagnostic Options in Graves' or Non‐Graves' Thyrotoxicosis: A ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/full/10.1111/cen.70192",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com"
    },
    {
      "number": 2,
      "title": "American Thyroid Association Guidelines for Diagnosis and Management of Thyroid Disease During Pregnancy Published in Thyroid Journal |  American Thyroid Association",
      "detail": "www.thyroid.org",
      "url": "https://www.thyroid.org/association-guidelines-management",
      "authors": "www.thyroid.org",
      "host": "www.thyroid.org"
    },
    {
      "number": 3,
      "title": "Vol 10 Issue 5 p.3-7 - American Thyroid Association",
      "detail": "www.thyroid.org",
      "url": "https://www.thyroid.org/patient-thyroid-information/ct-for-patients/may-2017/vol-10-issue-5-p-3-7",
      "authors": "www.thyroid.org",
      "host": "www.thyroid.org"
    },
    {
      "number": 4,
      "title": "Thyrotoxicosis - StatPearls - NCBI Bookshelf",
      "detail": "www.ncbi.nlm.nih.gov",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK482216",
      "authors": "www.ncbi.nlm.nih.gov",
      "host": "www.ncbi.nlm.nih.gov"
    },
    {
      "number": 5,
      "title": "Diagnosis and Treatment of Graves' Disease - Endotext - NCBI - NIH",
      "detail": "www.ncbi.nlm.nih.gov",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK285548",
      "authors": "www.ncbi.nlm.nih.gov",
      "host": "www.ncbi.nlm.nih.gov"
    },
    {
      "number": 6,
      "title": "Tests for people with confirmed thyrotoxicosis - NCBI Bookshelf",
      "detail": "www.ncbi.nlm.nih.gov",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK577229",
      "authors": "www.ncbi.nlm.nih.gov",
      "host": "www.ncbi.nlm.nih.gov"
    },
    {
      "number": 7,
      "title": "How to interpret thyroid function tests",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5922674",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov"
    },
    {
      "number": 8,
      "title": "Thyroid Function Tests - Clinical Methods - NCBI Bookshelf",
      "detail": "www.ncbi.nlm.nih.gov",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK249",
      "authors": "www.ncbi.nlm.nih.gov",
      "host": "www.ncbi.nlm.nih.gov"
    },
    {
      "number": 9,
      "title": "Graves' Disease | American Thyroid Association",
      "detail": "www.thyroid.org",
      "url": "https://www.thyroid.org/graves-disease",
      "authors": "www.thyroid.org",
      "host": "www.thyroid.org"
    }
  ],
  "editorialNote": "Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.",
  "citations": [
    {
      "number": 1,
      "title": "Diagnostic Options in Graves' or Non‐Graves' Thyrotoxicosis: A ...",
      "detail": "onlinelibrary.wiley.com",
      "url": "https://onlinelibrary.wiley.com/doi/full/10.1111/cen.70192",
      "authors": "onlinelibrary.wiley.com",
      "host": "onlinelibrary.wiley.com",
      "snippet": "The diagnostic accuracy of scintigraphy is approximately 96%. However, GD may also present with non-uniform or normal uptake in 5–12% of cases. The diagnostic",
      "score": 0.47504577
    },
    {
      "number": 2,
      "title": "American Thyroid Association Guidelines for Diagnosis and Management of Thyroid Disease During Pregnancy Published in Thyroid Journal |  American Thyroid Association",
      "detail": "www.thyroid.org",
      "url": "https://www.thyroid.org/association-guidelines-management",
      "authors": "www.thyroid.org",
      "host": "www.thyroid.org",
      "snippet": "The “2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum” were coauthored by an international task force of expert clinicians and researchers in the field of thyroidology. Led by Co-chairs Erik Alexander MD, Brig",
      "score": 0.6549173
    },
    {
      "number": 3,
      "title": "Vol 10 Issue 5 p.3-7 - American Thyroid Association",
      "detail": "www.thyroid.org",
      "url": "https://www.thyroid.org/patient-thyroid-information/ct-for-patients/may-2017/vol-10-issue-5-p-3-7",
      "authors": "www.thyroid.org",
      "host": "www.thyroid.org",
      "snippet": "Women who are already taking thyroid hormone replacement at the time pregnancy is confirmed (or even suspected) should contact their provider immediately; the task force recommends independently increasing the dose of their replacement hormone by taking two additional tablets weekly of their current",
      "score": 0.5737984
    },
    {
      "number": 4,
      "title": "Thyrotoxicosis - StatPearls - NCBI Bookshelf",
      "detail": "www.ncbi.nlm.nih.gov",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK482216",
      "authors": "www.ncbi.nlm.nih.gov",
      "host": "www.ncbi.nlm.nih.gov",
      "snippet": "Thyroid storm is diagnosed by low or undetectable TSH levels (<0.01 mU/L), elevated fT4 and fT3, or positive thyroid receptor antibodies. Due to its high mortality rate, clinicians should maintain a high index of suspicion in patients presenting with classic symptoms or relevant risk factors.(#artic",
      "score": 0.6429039
    },
    {
      "number": 5,
      "title": "Diagnosis and Treatment of Graves' Disease - Endotext - NCBI - NIH",
      "detail": "www.ncbi.nlm.nih.gov",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK285548",
      "authors": "www.ncbi.nlm.nih.gov",
      "host": "www.ncbi.nlm.nih.gov",
      "snippet": "The diagnosis of Graves’ disease is mostly straightforward, depending on recognition of the cardinal features of the disease and confirmation by tests including serum TSH, free T4, and TSH receptor antibodies. The differential diagnosis includes other causes of thyrotoxicosis, such as secretory thyr",
      "score": 0.5488434
    },
    {
      "number": 6,
      "title": "Tests for people with confirmed thyrotoxicosis - NCBI Bookshelf",
      "detail": "www.ncbi.nlm.nih.gov",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK577229",
      "authors": "www.ncbi.nlm.nih.gov",
      "host": "www.ncbi.nlm.nih.gov",
      "snippet": "with many centres (but not all) preferring TSHR-Ab to TPO-Ab for investigating a patient with suspected Graves’ disease. Furthermore, some centres also use thyroid isotope uptake scan and thyroid ultrasound for the investigation of thyrotoxicosis. There is currently no national standard, and there i",
      "score": 0.5300668
    },
    {
      "number": 7,
      "title": "How to interpret thyroid function tests",
      "detail": "pmc.ncbi.nlm.nih.gov",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5922674",
      "authors": "pmc.ncbi.nlm.nih.gov",
      "host": "pmc.ncbi.nlm.nih.gov",
      "snippet": "In any given individual, TH (thyroxine, T4; triiodothyronine, T3) levels remain relatively constant and reflect the ‘set-point’ of the hypothalamic–pituitary–thyroid (HPT) axis in that individual.3 Changes in thyroid status are typically associated with concordant changes in TH and TSH levels (eg ra",
      "score": 0.5195463
    },
    {
      "number": 8,
      "title": "Thyroid Function Tests - Clinical Methods - NCBI Bookshelf",
      "detail": "www.ncbi.nlm.nih.gov",
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK249",
      "authors": "www.ncbi.nlm.nih.gov",
      "host": "www.ncbi.nlm.nih.gov",
      "snippet": "A small overlap between normal and hyperthyroid patients is observed (Figure 142.1). Many hyperthyroid patients have less elevation of T4 than T3, and the diagnosis will be more readily appreciated by obtaining the latter determination. An occasional patient with hyperthyroidism, so called T3 toxico",
      "score": 0.41948205
    },
    {
      "number": 9,
      "title": "Graves' Disease | American Thyroid Association",
      "detail": "www.thyroid.org",
      "url": "https://www.thyroid.org/graves-disease",
      "authors": "www.thyroid.org",
      "host": "www.thyroid.org",
      "snippet": "The choice of initial diagnostic testing depends on cost, availability and local expertise. Measurement of antibodies, such as TRAb or TSI, is cost effective and if positive, confirms the diagnosis of Graves’ disease without further testing needed. If this test is negative (which can also occur in s",
      "score": 0.37641734
    }
  ],
  "publishedAt": "2026-09-15T18:33:20.751069+00:00",
  "updatedAt": "2026-09-15T18:33:20.751069+00:00",
  "readingMinutes": 6,
  "slug": "thyrotoxicosis-diagnostic-testing"
}